Detalhe da pesquisa
1.
TCR-independent CD137 (4-1BB) signaling promotes CD8+-exhausted T cell proliferation and terminal differentiation.
Immunity
; 56(7): 1631-1648.e10, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37392737
2.
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.
Immunity
; 53(4): 824-839.e10, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33053331
3.
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
Immunity
; 45(4): 774-787, 2016 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27742544
4.
SAR442085, a novel anti-CD38 antibody with enhanced antitumor activity against multiple myeloma.
Blood
; 139(8): 1160-1176, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201323
5.
TIGIT immune checkpoint blockade restores CD8+ T-cell immunity against multiple myeloma.
Blood
; 132(16): 1689-1694, 2018 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-29986909
6.
In situ expansion of T cells that recognize distinct self-antigens sustains autoimmunity in the CNS.
Brain
; 139(Pt 5): 1433-46, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27000832
7.
Bispecificity for myelin and neuronal self-antigens is a common feature of CD4 T cells in C57BL/6 mice.
J Immunol
; 193(7): 3267-77, 2014 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25135834
8.
Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model.
J Immunol
; 189(6): 3140-9, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22904307
9.
T cell apoptosis and induction of Foxp3+ regulatory T cells underlie the therapeutic efficacy of CD4 blockade in experimental autoimmune encephalomyelitis.
J Immunol
; 189(4): 1680-8, 2012 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22802417
10.
Invariant NKT cells inhibit development of the Th17 lineage.
Proc Natl Acad Sci U S A
; 106(15): 6238-43, 2009 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-19325124